# Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls

> **NCT01160263** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 16 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM

## Key facts

- **NCT ID:** NCT01160263
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01160263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01160263, "Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01160263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*